Skip to content
ppharmaranks
Menu

Best treatments for psychological sexual dysfunctions

2 products may treat psychological sexual dysfunctions, spanning FDA drug classes such as melanocortin receptor agonist. The current highest-rated option is vyleesi (autoinjector). Ranked below by our independent recall-safety rating (rated where FDA data exists) — not medical advice; always consult a professional.

Quick answer: Of the 2 drugs we list for psychological sexual dysfunctions, none are yet flagged as generics in our price data, spanning classes such as melanocortin receptor agonist. They’re ranked by each drug’s FDA recall-safety record — not clinical effectiveness for psychological sexual dysfunctions — so confirm the right choice with your prescriber.

Rated against independent regulatory sources·Last updated August 22, 2026·How we rate
Treatments we list for psychological sexual dysfunctions
#DrugRatingPharmacy pays
170/100View →
2Not yet ratedView →

Full ranking · 2 treatments

Frequently asked

What treats psychological sexual dysfunctions?
Our catalog lists 2 products that may treat psychological sexual dysfunctions, based on NIH RxClass (MED-RT “may treat”) drug-classification data — not the verbatim FDA label. They're rated where FDA recall-safety data exists; the current top-rated option is vyleesi (autoinjector).
What is the best-rated treatment for psychological sexual dysfunctions?
By our independent recall-safety rating — not an efficacy measure — vyleesi (autoinjector) ranks highest among the products we list for psychological sexual dysfunctions. Always consult a professional.
How are these treatments ranked?
By our independent score, currently based on FDA regulatory recall-safety data (the methodology blends additional sources as they come online). See the How we rate page.
What types of drugs treat psychological sexual dysfunctions?
Treatments for psychological sexual dysfunctions span FDA drug classes including melanocortin receptor agonist. Compare every option side by side, ranked by independent rating, above.

Treatment associations are derived from NIH RxClass (MED-RT “may treat”) drug-classification data — not the verbatim FDA label. This is general reference, not medical advice — always consult a licensed professional.